-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.O2.6 623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Clinical studies in Waldenstrom's Macroglobulinemia, Marginal Zone Lymphoma and Hairy Cell Leukemia

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
antibodies, Biological, Adult, Non-Biological, Diseases, Lymphoma (any), Marginal Zone Lymphoma, Combinations, Therapies, Elderly, chemotherapy, Non-Hodgkin Lymphoma, B-Cell Lymphoma, immunotherapy, Lymphoid Malignancies, Study Population, Clinically relevant, TKI
Sunday, December 6, 2020: 9:30 AM-11:00 AM
Christian Buske, MD, Comprehensive Cancer Center Ulm and Jorge J. Castillo, MD, Dana Farber Cancer Institute
Castillo: Abbvie: Research Funding; Beigene: Consultancy, Research Funding; Janssen: Consultancy, Research Funding; Pharmacyclics: Consultancy, Research Funding; TG Therapeutics: Research Funding; Kymera: Consultancy.
9:30 AM

Christian Buske, MD1, Alessandra Tedeschi, MD2*, Judith Trotman, MBChB, FRACP, FRCPA3*, Ramón García-Sanz, MD, PhD4*, David MacDonald, MD5, Veronique Leblond, MD, PhD6*, Béatrice Mahé, MD7*, Charles Herbaux, MD8*, Jeffrey V. Matous, MD9, Constantine S. Tam, MD10, Leonard T. Heffner, MD11*, Marzia Varettoni12*, M. Lia Palomba, MD13, Chaim Shustik, MD14, Efstathios Kastritis, MD15*, Steven P. Treon, MD, PhD16, Jerry Ping, PhD17*, Bernhard Hauns, MD, PhD17*, Israel Arango-Hisijara, MD17* and Meletios A Dimopoulos18

1Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany
2ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
3Concord Hospital, University of Sydney, Sydney, NSW, Australia
4Hospital Universitario de Salamanca, Salamanca, Spain
5The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
6Département d’ Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France
7Centre Hospitalier Universitaire de Nantes, Nantes, France
8Centre Hospitalier Régional Universitaire de Lille, Institute of Hematolog-Tranfusion, Lille, France
9Colorado Blood Cancer Institute, Denver, CO
10Peter MacCallum Cancer Centre & St. Vincent’s Hospital and the University of Melbourne, Melbourne, VIC, Australia
11Winship Cancer Institute of Emory University, Atlanta, GA
12Fondazione IRCCS Policlinico S. Matteo University of Pavia, Pavia, Italy
13Memorial Sloan Kettering Cancer Center, New York, NY
14Royal Victoria Hospital at McGill University Health Centre, Montreal, QC, Canada
15National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
16Dana-Farber Cancer Institute, Boston, MA
17Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
18University of Athens School of Medicine, KIFISIA, Greece

9:45 AM

Christian Buske, MD1, Meletios A Dimopoulos2, Alexander Grunenberg, MD3*, Efstathios Kastritis, MD4*, Cecile Tomowiak, MD5*, Béatrice Mahé, MD6*, Xavier Troussard, MD7, Roman Hajek, MD, PhD8, Andreas Viardot, Professor Dr9, Olivier Tournilhac10*, Therese Aurran11*, Stephane Lepretre, MD12*, Hacene Zerazhi, MD13*, Benedicte Hivert, MD14*, Veronique Leblond, MD, PhD15, Sophie de Guibert, MD16*, Lena Brandefors17*, Ramon Garcia-Sanz18, Maria Gomes da Silva, MD19*, Eva Kimby, MD, PhD20, Jens Dreyhaupt21*, Rainer Muche22* and Pierre Morel, MD23*

1Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany
2University of Athens School of Medicine, KIFISIA, Greece
3Department of Internal Medicine 3, University Hospital Ulm, Ulm, Germany
4Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece
5Hematology, Poitiers University Hospital / INSERM CIC 1402, Poitiers, France
6CHU Nantes Hôtel-Dieu, Nantes, France
7Department of Haematology, C.H.U. de Caen, Caen Cedex9, France
8Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
9Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
10Service d'Hematologie Clinique et de Therapie Cellulaire, CHU, Universite Clermont Auvergne, EA7453 CHELTER, CIC501, CLERMONT FERRAND, France
11Institut Paoli Calmettes, Marseille, France
12Centre Henri Becquerel and Normandie Univ UNIROUEN, Inserm U1245 and Department of Hematology, Rouen, France
13Clinical Hematology, Avignon Hospital, Avignon, France
14Centre Hospitalier Schaffner, Lens Cedex 9, Lens, France
15Service d'hématologie, Hopital Pitie-Salpetriere, Sorbonne Université, Paris, FRA
16Centre Hospitalier Pontchaillou, Rennes, FRA
17Sunderby Sjukhus, Lulea, SWE
18Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain
19Hematology Unit, Portuguese Institue of Oncology, Lisboa, Portugal
20Hematology, Karolinska Institute, Stockholm, Sweden
21University of Ulm, Institute of Epidemiology and Medical Biometry, Ulm, Germany
22University of Ulm, Ulm, Germany
23Department of Hematology, Chu Amiens, Salouel, France

10:00 AM

Tycel J. Phillips, MD1, Paolo Corradini2, Ronit Gurion, MD3*, Caterina Patti, MD4*, Monica Tani, MD5*, Abraham Avigdor, MD6,7, Wojciech Jurczak, MD, PhD8, Amitkumar Mehta, MD9, Pier Luigi Zinzani, MD10, Izidore S. Lossos, MD11, Catherine Thieblemont, MD, PhD12, Fred Zheng, MD13*, Erica Rappold13*, Wanying Zhao13* and Peter Johnson, MD, FRCP14

1Rogel Cancer Center, University of Michigan, Ann Arbor, MI
2University of Milano Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
3Department of Hematology, Rabin Medical Center & Tel Aviv University, Tel Aviv, Israel
4Department of Hematology I, Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
5Azienda Unità Sanitaria Locale della Romagna, Ospedale di Ravenna, Ravenna, Italy
6Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel
7Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
8Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
9University of Alabama School of Medicine, Birmingham, AL
10Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
11Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
12APHP, Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris Diderot, Paris, France
13Incyte Corporation, Wilmington, DE
14Cancer Research UK Centre, Southampton General Hospital, Southampton, United Kingdom

10:15 AM

Stephen Opat, FRACP, FRCPA, MBBS1,2*, Alessandra Tedeschi, MD3*, Kim Linton, MBChB, MRCP, PhD4*, Pamela McKay, MBChB (Hons), FRCP, FRCPath5*, Bei Hu, MD6, Henry Chan, MBChB, FRACP, FRCPA7, Jie Jin, MD, PhD8*, Pier Luigi Zinzani, MD9, Peter Browett, BMedSci, MBChB, FRACP, FRCPA10, Morton Coleman, MD11*, Magdalena Sobieraj-Teague, MBBS, FRACP, FRCPA, M.Sc12*, Xiaoyan Ke, MD, PhD13*, Mingyuan Sun, MD14*, Robert Marcus, MA, FRCP, FRCPath15*, Craig A. Portell, MD16, Keshu Zhou, MD, PhD17*, Catherine Thieblemont, MD, PhD18, Melannie Co, MD19*, Weige Wang, MD19*, Chris Tankersley, BS19*, Wenxiao Zhou, M.Sc19*, Massimo Cappellini, BS19*, Jane Huang, MD19* and Judith Trotman, MBChB, FRACP, FRCPA20,21*

1Monash University, Clayton, VIC, Australia
2Monash Health, Clayton, VIC, Australia
3ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
4The Christie, Manchester, United Kingdom
5Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
6Levine Cancer Institute/Atrium Health, Charlotte, NC
7North Shore Hospital, Auckland, New Zealand
8The First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China
9Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
10Auckland City Hospital, Grafton, New Zealand
11Clinical Research Alliance, Lake Success, NY
12Flinders Medical Centre, Bedford Park, SA, Australia
13Peking University Third Hospital, Beijing, CHN
14Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
15Sarah Cannon Research Institute UK, London, United Kingdom
16University of Virginia Health System, Charlottesville, VA
17Henan Cancer Hospital, Zhengzhou, Henan, China
18APHP, Hôpital Saint-Louis, Hemato-oncology, Paris University Diderot, Paris, France
19BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
20University of Sydney, Concord, NSW, Australia
21Concord Repatriation General Hospital, Concord, NSW, Australia

10:30 AM

Frederick Lansigan, MD1, David Jacob Andorsky, MD2, Morton Coleman, MD, FACP3*, Abdulraheem Yacoub, MD4*, Jason M. Melear, MD5, Suzanne R. Fanning, DO6, Kathryn S. Kolibaba, MD7, Christopher M. Reynolds, MD8*, Grzegorz S. Nowakowski, MD9, Mecide Gharibo, MD10, Erin Ahn, MS11*, Ju Li, PhD11*, Mathias J. Rummel, MD, PhD12* and Jeff P Sharman, MD13

1Dartmouth-Hitchcock Medical Center, Lebanon, NH
2Rocky Mountain Cancer Centers, US Oncology Research, Boulder, CO
3Clinical Research Alliance Inc., Weill Cornell Medicine, New York, NY
4University of Kansas Cancer Center, Westwood, KS
5Texas Oncology, Austin, TX
6Prisma Health, US Oncology Research, Greenville, SC
7US Oncology Research, Vancouver, WA
8IHA Hematology Oncology Consultants – Ann Arbor, Ypsilanti, MI
9Mayo Clinic, Rochester, MN
10Bristol-Myers Squibb, Princeton, NJ
11Bristol-Myers Squibb Company, Princeton, NJ
12Justus-Liebig Universität, Giessen, Germany
13Willamette Valley Cancer Institute and Research Center, US Oncology Research, Eugene, OR

10:45 AM

Marianna Criscuolo1*, Alessandro Broccoli2*, Eugenio Galli, MD3*, Alfonso Piciocchi, MS4*, Alessio Maraglino3*, Antonella Anastasia, MD5*, Ombretta Annibali6*, Maria Cantonetti7*, Maria Lucia De Luca, MD8*, Luana Fianchi, MD9*, Annamaria Frustaci10*, Elettra Galli11*, Luca Guarnera12*, Sofia Kovalchuk, MD13*, Francesco Marchesi14*, Marina Motta, MD5*, Maria Elena Nizzoli15*, Massimo Offidani16, Lorella Orsucci, MD17*, Angelica Spolzino18*, Caterina Stelitano, MD19*, Sergio Storti, MD20, Alessandra Tedeschi, MD21*, Livio Trentin, MD22,23, Marzia Varettoni24*, Andrea Visentin, MD PhD25*, Stefano Volpetti26*, Brunangelo Falini27*, Alessandro Pulsoni, MD8*, Enrico Tiacci28*, Pier Luigi Zinzani, MD29 and Livio Pagano, MD30*

1Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
2Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
3Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
4GIMEMA Foundation, Rome, Italy
5Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
6Unit of Hematology, Stem Cell Transplantation, University Campus Bio Medico, Rome, Italy
7University of Rome Tor Vergata, Rome, ITA
8Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
9Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
10Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
11Università degli Studi Firenze, Firenze, Italy
12Hematology, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Roma, Italy
13Hematology Department, University of Florence and AOU Careggi, Firenze, Italy
14Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute Rome, Italia, Roma, ITA
15Fondazione IRCCS Policlinico San Matteo, PAVIA, Italy
16Ematologia, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Italy
17Hematology Division, Città della Salute e della Scienza Hospital, Turin, Italy
18Hematology and BMT Unit, Università di Parma, Parma, Italy
19Department of Haematology, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
20Oncoematologia, Fondazione di Ricerca e Cura Giovanni Paolo II, Campobasso, ITA
21Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
22Hematology and Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy
23Hematology and Clinical Immunology, Department of Medicine, Dipartimento di Medicina Clinica e Sperimentale dell'Universita, Padova, Italy
24Fondazione IRCCS Policlinico S. Matteo University of Pavia, Pavia, Italy
25Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
26Clinica Ematologica, Centro Trapianti e Terapie Cellulari “C. Melzi”, DAME, Università degli Studi, Udine, Italy
27Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
28Institute of Hematology, University and Hospital of Perugia, Perugia, Italy
29Seragnoli Institute of Hematology, S. Orsola-Malpighi University Hospital, Bologna, Italy
30Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

*signifies non-member of ASH